See All Slides -

Slides

Presentation TCT 2016

Atrial Septostomy for Chronic Pulmonary Hypertension

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Gagan D Singh

November 01, 2016

Presentation TCT 2016

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Presenter: David P. Faxon, C. Michael Gibson, Roxana Mehran

November 01, 2016

Presentation TCT 2016

Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry

Presenter: Stephen G. Ellis, Patrick W. Serruys, Holger M. Nef

November 01, 2016

Presentation TCT 2016

Surgical Therapy for Chronic Pulmonary Thromboembolic Disease: Does it Work?

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Matthew D. Bacchetta

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Presenter: Philip M. Urban, Stephen G. Worthley, Robert-Jan van Geuns

November 01, 2016

Presentation TCT 2016

Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience

Presenter: Stephen G. Ellis, Patrick W. Serruys, Serban Puricel

November 01, 2016

Presentation TCT 2016

Portico: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Raj Makkar

November 01, 2016

Presentation TCT 2016

Hybrid/Guide Extension Reverse CART

Presenter: Alfredo R. Galassi, Masahiko Ochiai, Paul Knaapen

November 01, 2016

Presentation TCT 2016

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

Presenter: David P. Faxon, C. Michael Gibson

November 01, 2016

Presentation TCT 2016

FFR in the setting of CABG and AS/AVR/TAVR

Presenter: Bernard De Bruyne, Allen Jeremias, Emanuele Barbato

November 01, 2016

Advertisement

Slides

Atrial Septostomy for Chronic Pulmonary Hypertension

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Impact of the Learning Curve on BRS Outcomes: Experience From the GABI-R Registry

Surgical Therapy for Chronic Pulmonary Thromboembolic Disease: Does it Work?

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Impact of Implant Technique on Scaffold Thrombosis: The MICAT Experience

Portico: Design Features, Special Attributes, and Clinical Trial Program

Hybrid/Guide Extension Reverse CART

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

FFR in the setting of CABG and AS/AVR/TAVR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content